Michael S. Lidow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael S. Lidow has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ashiwel S. Undieh
Department of Psychiatry, Medical College of Pennsylvania, Philadelphia 19129
3 shared publications Fang He
Department of Biomedical Sciences and Program of Neuroscience, University of Maryland, Baltimore, 5-A-12, HHH, 666 W. Baltimore St., Baltimore, MD 21201, USA
3 shared publicationsJie Bai
Department of Biomedical Sciences, and Program of Neuroscience, University of Maryland, Baltimore, Maryland 21201
3 shared publicationsLing Zhang
Department of Biomedical Sciences, University of Maryland, Baltimore, MD 21201, USA
3 shared publicationsClare Bergson
2 shared publicationsIrina A. Lidow
Department of Biomedical Sciences and Program of Neuroscience, University of Maryland, Baltimore, 5-A-12, HHH, 666 W. Baltimore St., Baltimore, MD 21201, USA
2 shared publications
Latest Publications
- 1 March 2006
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 28 (2) , 181-197
Inhalational model of cocaine exposure in mice: Neuroteratological effects
- 1 March 2006
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 28 (2) , 181-197
Inhalational model of cocaine exposure in mice: Neuroteratological effects
Neuropathology of the cerebral cortex observed in a range of animal models of prenatal cocaine exposure may reflect alterations in genes involved in the Wnt and cadherin systems
Several recent reports show that the cerebral cortex in humans and animals with altered expressions of Wnt/cadherin network‐associate molecules display cytoarchitectural abnormalities reminiscent of cortical dysplasias seen in some (mouse‐, rat‐, and monkey‐based) animal models of prenatal cocaine exposure. Therefore, we employed oligo microarrays followed by real‐time RT‐PCR to compare expressions of genes involved in Wnt and cadherin systems in the cerebral wall of 18‐day‐old (E18) fetuses from cocaine‐treated (20 mg/kg cocaine, s.c., b.i.d., E8–18) and drug‐naive (saline, s.c.) mice. The pregnant mice chronically treated with cocaine in the above‐described manner represent one of the animal models producing offspring with widespread cortical dysplasias. Out of more than 150 relevant genes in the arrays, 32 were upregulated and 9 were downregulated in cocaine‐exposed fetuses. The majority of these genes (30 out of 41) were similarly affected in the frontal and occipital regions of the cerebral wall. We also used Western immunoblotting to examine the ability of cocaine to regulate the protein levels of β‐catenin, the key functional component of both Wnt and cadherin systems. While the total cell levels of β‐catenin were increased throughout the cerebral wall of cocaine‐exposed fetuses, its nuclear (gene‐transcription driving) levels remained unaltered. This suggests a transcription‐unrelated role for cocaine‐induced upregulation of this protein. Overall, our findings point to an intriguing possibility that that cerebral cortical dysplasias observed in several animal models of prenatal cocaine exposure may be at least in part related to alterations in the Wnt/cadherin molecular network. Synapse 56:105–116, 2005.
Neuropathology of the cerebral cortex observed in a range of animal models of prenatal cocaine exposure may reflect alterations in genes involved in the Wnt and cadherin systems
Several recent reports show that the cerebral cortex in humans and animals with altered expressions of Wnt/cadherin network‐associate molecules display cytoarchitectural abnormalities reminiscent of cortical dysplasias seen in some (mouse‐, rat‐, and monkey‐based) animal models of prenatal cocaine exposure. Therefore, we employed oligo microarrays followed by real‐time RT‐PCR to compare expressions of genes involved in Wnt and cadherin systems in the cerebral wall of 18‐day‐old (E18) fetuses from cocaine‐treated (20 mg/kg cocaine, s.c., b.i.d., E8–18) and drug‐naive (saline, s.c.) mice. The pregnant mice chronically treated with cocaine in the above‐described manner represent one of the animal models producing offspring with widespread cortical dysplasias. Out of more than 150 relevant genes in the arrays, 32 were upregulated and 9 were downregulated in cocaine‐exposed fetuses. The majority of these genes (30 out of 41) were similarly affected in the frontal and occipital regions of the cerebral wall. We also used Western immunoblotting to examine the ability of cocaine to regulate the protein levels of β‐catenin, the key functional component of both Wnt and cadherin systems. While the total cell levels of β‐catenin were increased throughout the cerebral wall of cocaine‐exposed fetuses, its nuclear (gene‐transcription driving) levels remained unaltered. This suggests a transcription‐unrelated role for cocaine‐induced upregulation of this protein. Overall, our findings point to an intriguing possibility that that cerebral cortical dysplasias observed in several animal models of prenatal cocaine exposure may be at least in part related to alterations in the Wnt/cadherin molecular network. Synapse 56:105–116, 2005.
- Open Access
- 1 January 2005
- Published by SAGE Publications in Molecular Pain
- Vol. 1, 27
Neonatal Local Noxious Insult Affects Gene Expression in the Spinal Dorsal Horn of Adult Rats
Neonatal noxious insult produces a long-term effect on pain processing in adults. Rats subjected to carrageenan (CAR) injection in one hindpaw within the sensitive period develop bilateral hypoalgesia as adults. In the same rats, inflammation of the hindpaw, which was the site of the neonatal injury, induces a localized enhanced hyperalgesia limited to this paw. To gain an insight into the long-term molecular changes involved in the above-described long-term nociceptive effects of neonatal noxious insult at the spinal level, we performed DNA microarray analysis (using microarrays containing oligo-probes for 205 genes encoding receptors and transporters for glutamate, GABA, and amine neurotransmitters, precursors and receptors for neuropeptides, and neurotrophins, cytokines and their receptors) to compare gene expression profiles in the lumbar spinal dorsal horn (LDH) of adult (P60) male rats that received neonatal CAR treatment within (at postnatal day 3; P3) and outside (at postnatal 12; P12) of the sensitive period. The data were obtained both without inflammation (at baseline) and during complete Freund's adjuvant induced inflammation of the neonatally injured paw. The observed changes were verified by real-time RT-PCR. This study revealed significant basal and inflammation-associated aberrations in the expression of multiple genes in the LDH of adult animals receiving CAR injection at P3 as compared to their expression levels in the LDH of animals receiving either no injections or CAR injection at P12. In particular, at baseline, twelve genes (representing GABA, serotonin, adenosine, neuropeptide Y, cholecystokinin, opioid, tachykinin and interleukin systems) were up-regulated in the bilateral LDH of the former animals. The baseline condition in these animals was also characterized by up-regulation of seven genes (encoding members of GABA, cholecystokinin, histamine, serotonin, and neurotensin systems) in the LDH ipsilateral to the neonatally-injured paw. The largest aberration in gene expression, however, was observed during inflammation of the neonatally injured hindpaws in the ipsilateral LDH, which included thirty-six genes (encoding numerous members of glutamate, serotonin, GABA, calcitonin gene-related peptide, neurotrophin, and interleukin systems). These findings suggest that changes in gene expression may be involved in the long-term nociceptive effects of neonatal noxious insult at the spinal level.
- 1 January 2005
- Published by SAGE Publications in Molecular Pain
- Vol. 1, 27
Open AccessNeonatal Local Noxious Insult Affects Gene Expression in the Spinal Dorsal Horn of Adult Rats
Neonatal noxious insult produces a long-term effect on pain processing in adults. Rats subjected to carrageenan (CAR) injection in one hindpaw within the sensitive period develop bilateral hypoalgesia as adults. In the same rats, inflammation of the hindpaw, which was the site of the neonatal injury, induces a localized enhanced hyperalgesia limited to this paw. To gain an insight into the long-term molecular changes involved in the above-described long-term nociceptive effects of neonatal noxious insult at the spinal level, we performed DNA microarray analysis (using microarrays containing oligo-probes for 205 genes encoding receptors and transporters for glutamate, GABA, and amine neurotransmitters, precursors and receptors for neuropeptides, and neurotrophins, cytokines and their receptors) to compare gene expression profiles in the lumbar spinal dorsal horn (LDH) of adult (P60) male rats that received neonatal CAR treatment within (at postnatal day 3; P3) and outside (at postnatal 12; P12) of the sensitive period. The data were obtained both without inflammation (at baseline) and during complete Freund's adjuvant induced inflammation of the neonatally injured paw. The observed changes were verified by real-time RT-PCR. This study revealed significant basal and inflammation-associated aberrations in the expression of multiple genes in the LDH of adult animals receiving CAR injection at P3 as compared to their expression levels in the LDH of animals receiving either no injections or CAR injection at P12. In particular, at baseline, twelve genes (representing GABA, serotonin, adenosine, neuropeptide Y, cholecystokinin, opioid, tachykinin and interleukin systems) were up-regulated in the bilateral LDH of the former animals. The baseline condition in these animals was also characterized by up-regulation of seven genes (encoding members of GABA, cholecystokinin, histamine, serotonin, and neurotensin systems) in the LDH ipsilateral to the neonatally-injured paw. The largest aberration in gene expression, however, was observed during inflammation of the neonatally injured hindpaws in the ipsilateral LDH, which included thirty-six genes (encoding numerous members of glutamate, serotonin, GABA, calcitonin gene-related peptide, neurotrophin, and interleukin systems). These findings suggest that changes in gene expression may be involved in the long-term nociceptive effects of neonatal noxious insult at the spinal level.
- 1 October 2004
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 27 (1) , 3-14
Cocaine-induced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall
- 1 October 2004
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 27 (1) , 3-14
Cocaine-induced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall
- Open Access
- 6 July 2004
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 15 (1) , 74-84
D1 Dopamine Receptor Regulation of the Levels of the Cell-cycle-controlling Proteins, Cyclin D, P27 and Raf-1, in Cerebral Cortical Precursor Cells is Mediated Through cAMP-independent Pathways
Previously, we demonstrated that dopamine D1 receptor (D1R) agonists inhibit epidermal growth factor (EGF)-induced passage of mouse fetal cerebral cortical precursor cells from the G1 phase to the S phase of the cell cycle. Here, we report that this action of D1R agonists may involve regulation of cyclin D, and P27, which respectively promote and suppress the G1 to S transition. Furthermore, regulation of Raf-1, a component of the receptor tyrosine kinase mitogen-activated protein kinase pathway engaged in the mitogenic activity of EGF, may also be involved. Specifically, levels of cyclin D and Raf-1 decrease, whereas those of P27 first increase and then decrease in a dose-dependent fashion in response to the D1R agonist, SKF38393. This agonist also promotes Raf-1 phosphorylation on serine 338 residue, suggesting increased activation of this protein. Only the latter effect can be blocked by adenylyl cyclase (AC) and cAMP-dependent protein kinase A (PKA) inhibitors, and mimicked by agonists of the cAMP signaling pathway. Another D1R agonist, SKF83959, which stimulates phospholipase Cβ (PLCβ) but not AC, reduces levels of Raf-1 and cyclin D similar to SKF38393. However, we detected only down-regulation of P27 by this agonist. Additionally, the concentration-dependent patterns of both SKF38393- and SKF83959-induced alterations in the levels of P27 closely resemble the effects of these ligands on the levels of the D1R–PLCβ-associated second-messenger cascades linker, calcyon. These findings suggest that D1R-induced suppression of the cell cycle progression in EGF-supported fetal cortical precursor cells represents a net effect of competing cell cycle promoting and inhibiting molecular changes, which involve cyclin D, P27 and Raf-1. The data also show that cAMP second messenger cascade is not engaged in the D1R-induced regulation of the levels of these three proteins. Such regulation probably involves PLCβ-associated pathways.
- 6 July 2004
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 15 (1) , 74-84
Open AccessD1 Dopamine Receptor Regulation of the Levels of the Cell-cycle-controlling Proteins, Cyclin D, P27 and Raf-1, in Cerebral Cortical Precursor Cells is Mediated Through cAMP-independent Pathways
Previously, we demonstrated that dopamine D1 receptor (D1R) agonists inhibit epidermal growth factor (EGF)-induced passage of mouse fetal cerebral cortical precursor cells from the G1 phase to the S phase of the cell cycle. Here, we report that this action of D1R agonists may involve regulation of cyclin D, and P27, which respectively promote and suppress the G1 to S transition. Furthermore, regulation of Raf-1, a component of the receptor tyrosine kinase mitogen-activated protein kinase pathway engaged in the mitogenic activity of EGF, may also be involved. Specifically, levels of cyclin D and Raf-1 decrease, whereas those of P27 first increase and then decrease in a dose-dependent fashion in response to the D1R agonist, SKF38393. This agonist also promotes Raf-1 phosphorylation on serine 338 residue, suggesting increased activation of this protein. Only the latter effect can be blocked by adenylyl cyclase (AC) and cAMP-dependent protein kinase A (PKA) inhibitors, and mimicked by agonists of the cAMP signaling pathway. Another D1R agonist, SKF83959, which stimulates phospholipase Cβ (PLCβ) but not AC, reduces levels of Raf-1 and cyclin D similar to SKF38393. However, we detected only down-regulation of P27 by this agonist. Additionally, the concentration-dependent patterns of both SKF38393- and SKF83959-induced alterations in the levels of P27 closely resemble the effects of these ligands on the levels of the D1R–PLCβ-associated second-messenger cascades linker, calcyon. These findings suggest that D1R-induced suppression of the cell cycle progression in EGF-supported fetal cortical precursor cells represents a net effect of competing cell cycle promoting and inhibiting molecular changes, which involve cyclin D, P27 and Raf-1. The data also show that cAMP second messenger cascade is not engaged in the D1R-induced regulation of the levels of these three proteins. Such regulation probably involves PLCβ-associated pathways.
- 1 May 2004
- Published by Wolters Kluwer Health in Pain
Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflamatory insult
Recently, several studies have suggested that neonatal noxious insult could alter future responses to painful stimuli. However, the manifestations, mechanisms, and even developmental nature of these alterations remain a matter of controversy. In part, this is due to the lack of detailed information on the neonatal sensitive period(s) during which noxious stimulation influences future nociception, and the time-course and distribution of the resultant abnormalities. The present paper describes these parameters in a rat model of short-lasting (∼24 h) neonatal local inflammation of a hindpaw produced by injection of 0.25% carrageenan (1 μl/g). Examinations of paw withdrawal responses to thermal and mechanical stimulations in adult animals, which as neonates were subjected to this insult, showed that the previously-reported long-term hypoalgesia and hyperalgesia are not mutually exclusive outcomes of early noxious experience. Long-term hypoalgesia was apparent at the basal conditions and was equally strong in the previously injured and uninjured paws, which suggests a globally-driven deficit. In contrast, long-term excessive hyperalgesia had the strongest manifestation in the neonatally-injured paw after re-inflammation, indicating significant segmental involvement in its generation. The differences between mechanisms underlying the observed hypoalgesia and hyperalgesia are further underscored by the finding that, while the former is detectable only after animals reach the second month of life, the latter is elicitable immediately upon cessation of the initial neonatal inflammation. Nevertheless, we detected a significant overlap in the neonatal sensitive periods for generation of these effects (both occurring within the first postnatal week). Also, neither the basal hypoalgesia nor excessive re-inflammation-associated hyperalgesia subsided with age and were detectable in 120–125-day-old rats. These finding provide a framework within which the entire complex of long-term effects of early noxious experience can be understood and examined.
- 1 May 2004
- Published by Wolters Kluwer Health in Pain
Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflamatory insult
Recently, several studies have suggested that neonatal noxious insult could alter future responses to painful stimuli. However, the manifestations, mechanisms, and even developmental nature of these alterations remain a matter of controversy. In part, this is due to the lack of detailed information on the neonatal sensitive period(s) during which noxious stimulation influences future nociception, and the time-course and distribution of the resultant abnormalities. The present paper describes these parameters in a rat model of short-lasting (∼24 h) neonatal local inflammation of a hindpaw produced by injection of 0.25% carrageenan (1 μl/g). Examinations of paw withdrawal responses to thermal and mechanical stimulations in adult animals, which as neonates were subjected to this insult, showed that the previously-reported long-term hypoalgesia and hyperalgesia are not mutually exclusive outcomes of early noxious experience. Long-term hypoalgesia was apparent at the basal conditions and was equally strong in the previously injured and uninjured paws, which suggests a globally-driven deficit. In contrast, long-term excessive hyperalgesia had the strongest manifestation in the neonatally-injured paw after re-inflammation, indicating significant segmental involvement in its generation. The differences between mechanisms underlying the observed hypoalgesia and hyperalgesia are further underscored by the finding that, while the former is detectable only after animals reach the second month of life, the latter is elicitable immediately upon cessation of the initial neonatal inflammation. Nevertheless, we detected a significant overlap in the neonatal sensitive periods for generation of these effects (both occurring within the first postnatal week). Also, neither the basal hypoalgesia nor excessive re-inflammation-associated hyperalgesia subsided with age and were detectable in 120–125-day-old rats. These finding provide a framework within which the entire complex of long-term effects of early noxious experience can be understood and examined.
- 31 December 2003
- Published by Elsevier in Brain Research Reviews
- Vol. 43 (3) , 285
Corrigendum to “Calcium signaling dysfunction in schizophrenia: a unifying approach” [Brain Research Reviews 43 (2003) 70–84]
- 31 December 2003
- Published by Elsevier in Brain Research Reviews
- Vol. 43 (3) , 285
Corrigendum to “Calcium signaling dysfunction in schizophrenia: a unifying approach” [Brain Research Reviews 43 (2003) 70–84]
- 1 December 2003
- Published by Elsevier in Developmental Brain Research
- Vol. 147 (1-2) , 23-36
Consequences of prenatal cocaine exposure in nonhuman primates
- 1 December 2003
- Published by Elsevier in Developmental Brain Research
- Vol. 147 (1-2) , 23-36
Consequences of prenatal cocaine exposure in nonhuman primates
- 1 September 2003
- Published by Elsevier in Brain Research Reviews
- Vol. 43 (1) , 70-84
Calcium signaling dysfunction in schizophrenia: a unifying approach
- 1 September 2003
- Published by Elsevier in Brain Research Reviews
- Vol. 43 (1) , 70-84
Calcium signaling dysfunction in schizophrenia: a unifying approach
- Open Access
- 1 March 2003
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 60 (3) , 311-319
Up-regulation of the D1 Dopamine Receptor–Interacting Protein, Calcyon, in Patients With Schizophrenia
THE DOPAMINE hypothesis continues to guide biological research in schizophrenia despite difficulties in identifying a clear disease-associated abnormality in the presynaptic or postsynaptic components of the brain's dopamine system.1- 4 This hypothesis is founded in large part on the therapeutic efficacy of antipsychotic medications, universally attributed to their action at D2 dopamine receptors.2,5- 7 It has been argued that antipsychotic drug treatment may also affect D1 dopamine receptors.2,6,8- 12 Furthermore, D1 receptor involvement in schizophrenia is suggested by the ability of D1 receptor–acting drugs to alter working memory performance,6,10,13- 19 an abnormality that is now widely recognized to be a core feature of schizophrenia.6,13,14,20,21 Both suppression and overstimulation of D1 receptor activity have been shown to result in working memory deficits.15
- 1 March 2003
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 60 (3) , 311-319
Open AccessUp-regulation of the D1 Dopamine Receptor–Interacting Protein, Calcyon, in Patients With Schizophrenia
THE DOPAMINE hypothesis continues to guide biological research in schizophrenia despite difficulties in identifying a clear disease-associated abnormality in the presynaptic or postsynaptic components of the brain's dopamine system.1- 4 This hypothesis is founded in large part on the therapeutic efficacy of antipsychotic medications, universally attributed to their action at D2 dopamine receptors.2,5- 7 It has been argued that antipsychotic drug treatment may also affect D1 dopamine receptors.2,6,8- 12 Furthermore, D1 receptor involvement in schizophrenia is suggested by the ability of D1 receptor–acting drugs to alter working memory performance,6,10,13- 19 an abnormality that is now widely recognized to be a core feature of schizophrenia.6,13,14,20,21 Both suppression and overstimulation of D1 receptor activity have been shown to result in working memory deficits.15